medigraphic.com
ISSN 0035-0052 (Print)

2018, Number 2

<< Back Next >>

Rev Mex Pediatr 2018; 85 (2)

Chikungunya in children: emergency of a new disease in Sonora Mexico. Presentation of 6 clinical cases

Gómez-Rivera N, Gómez-Jiménez IA, Alomía-Zegarra JL, Fonseca-Chon I, García-Zárate MG, Gómez-Figueroa CO, Villalobos-García L

Language: Spanish
References: 32
Page: 66-69
PDF size: 216.64 Kb.


ABSTRACT

Objective: To describe the clinical and laboratory characteristics of the exanthematous disease by chikungunya virus (CHIKV). Material and methods: Review of clinical files with diagnosis of CHIKV occurred in the Children’s Hospital of the State of Sonora, during the year 2015. Results: Five cases were resolved without complications in the acute phase and one case developed arthritis and arthralgia with three months of evolution without presenting orthopedic sequelae. One case with mild thrombocytopenia, four children developed lymphopenia and one case with neutropenia, leukopenia and lymphopenia. Conclusions: All six cases presented a favorable evolution; no child had the characteristic feature of buckling disease due to pain or any sequelae.


REFERENCES

  1. Barrett A, Weaver S. Arboviruses: alphaviruses, flaviviruses and bunyaviruses. Medical Microbiology. Churchill Livingstone; 2002. pp. 484-501.

  2. Staples JE, Fischer M. Chikungunya virus in the Americas--what a vector borne pathogen can do. N Engl J Med. 2014; 371(10): 887-889.

  3. Vu DM, Jungkind D, Angelle-Desiree L. Chikungunya virus. Clin Lab Med. 2017; 37(2): 371-382.

  4. Halstead S, Feigin R, Cherry J, Demmler G. Textbook of pediatric infectious diseases. Philadelphia: Saunders; 2004. pp. 2178-2184.

  5. Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015; 372(13): 1231-1239.

  6. Vasconcelos PF, Calisher C. Emergence of human arboviral diseases in the Americas, 2000-2016. Vector Borne Zoonotic Dis. 2016; 16(5): 295-301.

  7. Ramful D, Carbonnier M, Pasquet M, Bouhmani B, Ghazouani J, Noormahomed T et al. Mother-to-child transmission of Chikungunya virus infection. Pediatr Infect Dis J. 2007; 26(9): 811-815.

  8. Ramful D, Sampériz S, Fritel X, Michault A, Jaffar-Bandjee MC, Rollot O et al. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis. 2014; 209(11): 1726-1730.

  9. Rosario V, Munoz-Louis R, Valdez T, Adames S, Medrano J, Paulino I et al. Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy. Clin Rheumatol. 2015; 34(7): 1285-1287.

  10. Robin S, Ramful D, Le Seach’ F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008; 23(9): 1028-1035.

  11. Méndez-Domínguez N, Achach-Asaf JA, Basso-García LM, Quiñones-Pacheco YB, Gómez-Carro S. Choque séptico secundario a fiebre por chikungunya no congénita en un lactante menor: caso clínico. Rev Chil Pediatr. 2016; 87(2): 143-147.

  12. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr. 2009; 76(2): 185-189.

  13. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profile of Chikungunya in infants. Indian J Pediatr. 2009; 76(2): 151-155.

  14. Mourya DT, Yadav P. Vector biology of dengue & chikungunya viruses. Indian J Med Res. 2006; 124(5): 475-480.

  15. Crosby L, Perreau C, Madeux B, Cossic J, Armand C, Herrmann-Storke C et al. Severe manifestations of chikungunya virus in critically ill patients during the 2013-2014 Caribbean outbreak. Int J Infect Dis. 2016; 48: 78-80.

  16. Jadhav M, Namboodripad M, Carman RH, Carey DE, Myers RM. Chikungunya disease in infants and children in Vellore: a report of clinical and haematological features of virologically proved cases. Indian J Med Res. 1965; 53(8): 764-776.

  17. Mercado M, Acosta-Reyes J, Parra E, Pardo L, Rico A, Campo A et al. Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015. Euro Surveill. 2016; 21(22). doi: 10.2807/1560-7917.ES.2016.21.22.30244.

  18. Galindo-Fraga A, Ochoa-Hein E, Sifuentes-Osornio J, Ruiz-Palacios G. Zika virus: a new epidemic on our doorstep. Rev Invest Clin. 2015; 67(6): 329-332.

  19. Kantor IN. Dengue, zika and chikungunya. Medicina (B Aires). 2016; 76(2): 93-97.

  20. Ali Ou Alla S, Combe B. Arthritis after infection with Chikungunya virus. Best Pract Res Clin Rheumatol. 2011; 25(3): 337-346.

  21. Miner JJ, Aw-Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015; 67(5): 1214-1220.

  22. Raghavendhar BS, Ray P, Ratagiri VH, Sharma BS, Kabra SK, Lodha R. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study. J Med Virol. 2016; 88(6): 923-930.

  23. Gómez-Rivera N, Mada-Velez JG. Brote de dengue en población pediátrica. 530 casos. Bol Clin Infant Edo Son. 1998; 15: 71-76.

  24. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009; 76(6): 654-657.

  25. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969; 18(6): 954-971.

  26. Carbajo AE, Vezzani D. Waiting for chikungunya fever in Argentina: spatio-temporal risk maps. Mem Inst Oswaldo Cruz. 2015; 110(2): 259-262.

  27. Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg. 2012; 86(4): 720-723.

  28. Thiberville SD, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013; 99(3): 345-370.

  29. Chen MW, Tan YB, Zheng J, Zhao Y, Lim BT, Cornvik T et al. Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities. Antiviral Res. 2017; 143: 38-47.

  30. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2009; 137(4): 534-541.

  31. Rothan HA, Bahrani H, Abdulrahman AY, Mohamed Z, Teoh TC, Othman S et al. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. Antiviral Res. 2016; 127: 50-56.

  32. Mohan A. Chikungunya fever: clinical manifestations & management. Indian J Med Res. 2006; 124(5): 471-474.




2020     |     www.medigraphic.com